Gasco, Beberly A.

HRN: 13-36-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/03/2026
05/10/2026
IV
300mg
Q 8 Hours
DM Foot
Checking Initial Appropriateness 
05/04/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/04/2026
05/11/2026
IV
600mg
Q8
Skin And Soft Tissue Infection
Checking Initial Appropriateness 
05/04/2026
CEFTRIAXONE 1G (VIAL)
05/04/2026
05/11/2026
IV
2g
Od
UTI
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: